Engineering Drug Development Through Predictive Intelligence
From Molecular Uncertainty to Clinical Precision
We identify high-value therapeutic opportunities and systematically transform them into development-ready assets through predictive modelling, formulation engineering, and translational strategy.
Not discovery for its own sake—but engineering what already works into what is clinically viable.
Drug development does not fail for lack of biology—it fails at translation
Across therapeutic areas, the same pattern repeats: molecules demonstrate strong biological rationale, early signals are promising, yet clinical success remains inconsistent.
The failure point is rarely discovery.
It lies in:
- Poor predictability of human pharmacokinetics
- Inadequate formulation strategies
- Fragmented CMC and regulatory alignment
We exist to solve this exact problem
A unified system for drug development
Every programme at Dhee is built through an integrated framework:
INPUT
Scientific Insight
Intelligence
SynapTx Layer
Engineering
Formulation
Strategy
Translational
Output
Clinical-Ready Asset
This is not a linear process—it is a structured, iterative system designed to reduce uncertainty at every stage.
A portfolio built on solving high-value bottlenecks
Molecule Rescue Platforms
Unlocking clinically validated molecules limited by delivery and formulation barriers.
Biology works—but delivery fails
Delivery & Exposure Engineering Platforms
Engineering precise pharmacokinetics and controlled activation.
Exposure is unpredictable and poorly controlled
Translational Systems & Microenvironment Engineering
Redefining how drugs interact with complex biological environments.
Biology is structurally inaccessible
SynapTx — The Intelligence Core
A proprietary intelligence layer that transforms fragmented scientific data into actionable development strategy.
- Predictive pharmacokinetic modelling
- Evidence synthesis across literature and patents
- Formulation and stability prediction
- Development pathway optimisation
This is the layer that connects every platform.
A single philosophy across multiple domains
Clinically Relevant, Not Hypothetical
We focus on known molecules, validated mechanisms, and real therapeutic gaps—not speculative targets.
Validated Mechanisms
Real Gaps
Known Molecules
Bottleneck-Driven Selection
We prioritise opportunities where failure is driven by delivery limitations, stability constraints, or translational gaps—not scientific novelty alone.
Delivery Limits
Stability
Translational Gaps
Engineering-Led Solutions
We solve through advanced formulation science, predictive modelling, and integrated CMC and regulatory strategy.
Formulation Science
Predictive Modelling
CMC & Regulatory
Engineering delivery beyond formulation
We do not rely on a single technology. Each programme is approached through a multi-layered delivery engineering framework, designed to solve the specific bottleneck limiting clinical translation.
01
Microenvironment Engineering
- Stabilising highly reactive intermediates (e.g., HNO donors)
- Creating protected internal environments within carriers
- Modulating tissue architecture to enhance penetration
02
Controlled & Sustained Release Architectures
- Injectable depots (hydrogels, microspheres)
- Matrix-driven release systems
- Multi-phase release profiles (immediate + sustained)
03
Targeted & Triggered Activation Systems
- Enzyme-responsive systems (MMP, esterase-triggered)
- Tumour or disease microenvironment activation
- Masked prodrugs and linker-based activation
04
Precision Dosing & Exposure Control
- Metered micro-dosing architectures
- Transdermal and alternative delivery systems
- Controlled permeation and absorption kinetics
05
Solubility & Stability Engineering
- Advanced solubilisation strategies
- Encapsulation (where appropriate—not assumed)
- Excipient system optimisation
- Protection against degradation pathways
06
Platform-Agnostic Integration
- ADCs combining biologics + linker chemistry + CMC control
- Prodrugs requiring masking + activation + solubility engineering
- ECM systems integrating materials science + biology + delivery
We do not optimise formulations.
We engineer how molecules survive, move, activate, and perform in real biological systems.
Execution, Not Just Insight
Insight is only valuable if it translates into reality
Unlike purely computational or advisory approaches, we deliver across every stage.
Design the Strategy
Evidence synthesis, PK modelling, and development pathway selection.
Engineer the Formulation
Applied formulation science from concept through to manufacturable system.
Align with Regulation
CMC and regulatory strategy integrated from the outset, not retrofitted.
Enable Real-World Execution
From concept to clinic—not just concept to report.
Collaboration Model
Multiple pathways to partnership
Co-Development
Engineer the Formulation
Platform Integration
Technology Co-Creation
Collaboration Model
We operate where most pipelines break down
WELL-ESTABLISHED
Discovery
Clinical Trials
The Space In Between
Is where
we operate
UNDER-ENGINEERED
PK & Translation
Formulation Strategy
CMC Alignment
Development Readiness